Global Neutropenia Biologic Drug Treatment Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Neutropenia Biologic Drug Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Neutropenia Biologic Drug Treatment market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Neutropenia Biologic Drug Treatment market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Neutropenia Biologic Drug Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Neutropenia Biologic Drug Treatment market, reaching US$ million by the year 2028. As for the Europe Neutropenia Biologic Drug Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Neutropenia Biologic Drug Treatment players cover Amgen, Novartis, Pfizer, and Baxter International, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Neutropenia Biologic Drug Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Neutropenia Biologic Drug Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Neutropenia Biologic Drug Treatment market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Neutropenia Biologic Drug Treatment market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Neutropenia Biologic Drug Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Neutropenia Biologic Drug Treatment market, reaching US$ million by the year 2028. As for the Europe Neutropenia Biologic Drug Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Neutropenia Biologic Drug Treatment players cover Amgen, Novartis, Pfizer, and Baxter International, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Neutropenia Biologic Drug Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Filgrastim
- Pegfilgrastim
- Lenograstim
- Lipegfilgrastim
- Sargramostim
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen
- Novartis
- Pfizer
- Baxter International
- Cellerant Therapeutics
- Dong-A ST Co.,Ltd.
- Myelo Therapeutics GmbH
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- Kyowa Kirin
- CVS Health
- Partner Therapeutics
- Enzychem Lifesciences Corporation
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neutropenia Biologic Drug Treatment Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Neutropenia Biologic Drug Treatment by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Neutropenia Biologic Drug Treatment by Country/Region, 2017, 2022 & 2028
2.2 Neutropenia Biologic Drug Treatment Segment by Type
2.2.1 Filgrastim
2.2.2 Pegfilgrastim
2.2.3 Lenograstim
2.2.4 Lipegfilgrastim
2.2.5 Sargramostim
2.3 Neutropenia Biologic Drug Treatment Sales by Type
2.3.1 Global Neutropenia Biologic Drug Treatment Sales Market Share by Type (2017-2022)
2.3.2 Global Neutropenia Biologic Drug Treatment Revenue and Market Share by Type (2017-2022)
2.3.3 Global Neutropenia Biologic Drug Treatment Sale Price by Type (2017-2022)
2.4 Neutropenia Biologic Drug Treatment Segment by Application
2.4.1 Retail Pharmacies
2.4.2 Hospital Pharmacies
2.4.3 Online Pharmacies
2.5 Neutropenia Biologic Drug Treatment Sales by Application
2.5.1 Global Neutropenia Biologic Drug Treatment Sale Market Share by Application (2017-2022)
2.5.2 Global Neutropenia Biologic Drug Treatment Revenue and Market Share by Application (2017-2022)
2.5.3 Global Neutropenia Biologic Drug Treatment Sale Price by Application (2017-2022)
3 GLOBAL NEUTROPENIA BIOLOGIC DRUG TREATMENT BY COMPANY
3.1 Global Neutropenia Biologic Drug Treatment Breakdown Data by Company
3.1.1 Global Neutropenia Biologic Drug Treatment Annual Sales by Company (2020-2022)
3.1.2 Global Neutropenia Biologic Drug Treatment Sales Market Share by Company (2020-2022)
3.2 Global Neutropenia Biologic Drug Treatment Annual Revenue by Company (2020-2022)
3.2.1 Global Neutropenia Biologic Drug Treatment Revenue by Company (2020-2022)
3.2.2 Global Neutropenia Biologic Drug Treatment Revenue Market Share by Company (2020-2022)
3.3 Global Neutropenia Biologic Drug Treatment Sale Price by Company
3.4 Key Manufacturers Neutropenia Biologic Drug Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neutropenia Biologic Drug Treatment Product Location Distribution
3.4.2 Players Neutropenia Biologic Drug Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NEUTROPENIA BIOLOGIC DRUG TREATMENT BY GEOGRAPHIC REGION
4.1 World Historic Neutropenia Biologic Drug Treatment Market Size by Geographic Region (2017-2022)
4.1.1 Global Neutropenia Biologic Drug Treatment Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Neutropenia Biologic Drug Treatment Annual Revenue by Geographic Region
4.2 World Historic Neutropenia Biologic Drug Treatment Market Size by Country/Region (2017-2022)
4.2.1 Global Neutropenia Biologic Drug Treatment Annual Sales by Country/Region (2017-2022)
4.2.2 Global Neutropenia Biologic Drug Treatment Annual Revenue by Country/Region
4.3 Americas Neutropenia Biologic Drug Treatment Sales Growth
4.4 APAC Neutropenia Biologic Drug Treatment Sales Growth
4.5 Europe Neutropenia Biologic Drug Treatment Sales Growth
4.6 Middle East & Africa Neutropenia Biologic Drug Treatment Sales Growth
5 AMERICAS
5.1 Americas Neutropenia Biologic Drug Treatment Sales by Country
5.1.1 Americas Neutropenia Biologic Drug Treatment Sales by Country (2017-2022)
5.1.2 Americas Neutropenia Biologic Drug Treatment Revenue by Country (2017-2022)
5.2 Americas Neutropenia Biologic Drug Treatment Sales by Type
5.3 Americas Neutropenia Biologic Drug Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neutropenia Biologic Drug Treatment Sales by Region
6.1.1 APAC Neutropenia Biologic Drug Treatment Sales by Region (2017-2022)
6.1.2 APAC Neutropenia Biologic Drug Treatment Revenue by Region (2017-2022)
6.2 APAC Neutropenia Biologic Drug Treatment Sales by Type
6.3 APAC Neutropenia Biologic Drug Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neutropenia Biologic Drug Treatment by Country
7.1.1 Europe Neutropenia Biologic Drug Treatment Sales by Country (2017-2022)
7.1.2 Europe Neutropenia Biologic Drug Treatment Revenue by Country (2017-2022)
7.2 Europe Neutropenia Biologic Drug Treatment Sales by Type
7.3 Europe Neutropenia Biologic Drug Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neutropenia Biologic Drug Treatment by Country
8.1.1 Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Country (2017-2022)
8.1.2 Middle East & Africa Neutropenia Biologic Drug Treatment Revenue by Country (2017-2022)
8.2 Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Type
8.3 Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neutropenia Biologic Drug Treatment
10.3 Manufacturing Process Analysis of Neutropenia Biologic Drug Treatment
10.4 Industry Chain Structure of Neutropenia Biologic Drug Treatment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neutropenia Biologic Drug Treatment Distributors
11.3 Neutropenia Biologic Drug Treatment Customer
12 WORLD FORECAST REVIEW FOR NEUTROPENIA BIOLOGIC DRUG TREATMENT BY GEOGRAPHIC REGION
12.1 Global Neutropenia Biologic Drug Treatment Market Size Forecast by Region
12.1.1 Global Neutropenia Biologic Drug Treatment Forecast by Region (2023-2028)
12.1.2 Global Neutropenia Biologic Drug Treatment Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neutropenia Biologic Drug Treatment Forecast by Type
12.7 Global Neutropenia Biologic Drug Treatment Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Neutropenia Biologic Drug Treatment Product Offered
13.1.3 Amgen Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Neutropenia Biologic Drug Treatment Product Offered
13.2.3 Novartis Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Neutropenia Biologic Drug Treatment Product Offered
13.3.3 Pfizer Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Baxter International
13.4.1 Baxter International Company Information
13.4.2 Baxter International Neutropenia Biologic Drug Treatment Product Offered
13.4.3 Baxter International Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Baxter International Main Business Overview
13.4.5 Baxter International Latest Developments
13.5 Cellerant Therapeutics
13.5.1 Cellerant Therapeutics Company Information
13.5.2 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Offered
13.5.3 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Cellerant Therapeutics Main Business Overview
13.5.5 Cellerant Therapeutics Latest Developments
13.6 Dong-A ST Co.,Ltd.
13.6.1 Dong-A ST Co.,Ltd. Company Information
13.6.2 Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Product Offered
13.6.3 Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Dong-A ST Co.,Ltd. Main Business Overview
13.6.5 Dong-A ST Co.,Ltd. Latest Developments
13.7 Myelo Therapeutics GmbH
13.7.1 Myelo Therapeutics GmbH Company Information
13.7.2 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Product Offered
13.7.3 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Myelo Therapeutics GmbH Main Business Overview
13.7.5 Myelo Therapeutics GmbH Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi Neutropenia Biologic Drug Treatment Product Offered
13.8.3 Sanofi Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Teva Pharmaceutical Industries Ltd.
13.9.1 Teva Pharmaceutical Industries Ltd. Company Information
13.9.2 Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Product Offered
13.9.3 Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.9.5 Teva Pharmaceutical Industries Ltd. Latest Developments
13.10 Kyowa Kirin
13.10.1 Kyowa Kirin Company Information
13.10.2 Kyowa Kirin Neutropenia Biologic Drug Treatment Product Offered
13.10.3 Kyowa Kirin Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Kyowa Kirin Main Business Overview
13.10.5 Kyowa Kirin Latest Developments
13.11 CVS Health
13.11.1 CVS Health Company Information
13.11.2 CVS Health Neutropenia Biologic Drug Treatment Product Offered
13.11.3 CVS Health Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 CVS Health Main Business Overview
13.11.5 CVS Health Latest Developments
13.12 Partner Therapeutics
13.12.1 Partner Therapeutics Company Information
13.12.2 Partner Therapeutics Neutropenia Biologic Drug Treatment Product Offered
13.12.3 Partner Therapeutics Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Partner Therapeutics Main Business Overview
13.12.5 Partner Therapeutics Latest Developments
13.13 Enzychem Lifesciences Corporation
13.13.1 Enzychem Lifesciences Corporation Company Information
13.13.2 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Offered
13.13.3 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Enzychem Lifesciences Corporation Main Business Overview
13.13.5 Enzychem Lifesciences Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neutropenia Biologic Drug Treatment Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Neutropenia Biologic Drug Treatment by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Neutropenia Biologic Drug Treatment by Country/Region, 2017, 2022 & 2028
2.2 Neutropenia Biologic Drug Treatment Segment by Type
2.2.1 Filgrastim
2.2.2 Pegfilgrastim
2.2.3 Lenograstim
2.2.4 Lipegfilgrastim
2.2.5 Sargramostim
2.3 Neutropenia Biologic Drug Treatment Sales by Type
2.3.1 Global Neutropenia Biologic Drug Treatment Sales Market Share by Type (2017-2022)
2.3.2 Global Neutropenia Biologic Drug Treatment Revenue and Market Share by Type (2017-2022)
2.3.3 Global Neutropenia Biologic Drug Treatment Sale Price by Type (2017-2022)
2.4 Neutropenia Biologic Drug Treatment Segment by Application
2.4.1 Retail Pharmacies
2.4.2 Hospital Pharmacies
2.4.3 Online Pharmacies
2.5 Neutropenia Biologic Drug Treatment Sales by Application
2.5.1 Global Neutropenia Biologic Drug Treatment Sale Market Share by Application (2017-2022)
2.5.2 Global Neutropenia Biologic Drug Treatment Revenue and Market Share by Application (2017-2022)
2.5.3 Global Neutropenia Biologic Drug Treatment Sale Price by Application (2017-2022)
3 GLOBAL NEUTROPENIA BIOLOGIC DRUG TREATMENT BY COMPANY
3.1 Global Neutropenia Biologic Drug Treatment Breakdown Data by Company
3.1.1 Global Neutropenia Biologic Drug Treatment Annual Sales by Company (2020-2022)
3.1.2 Global Neutropenia Biologic Drug Treatment Sales Market Share by Company (2020-2022)
3.2 Global Neutropenia Biologic Drug Treatment Annual Revenue by Company (2020-2022)
3.2.1 Global Neutropenia Biologic Drug Treatment Revenue by Company (2020-2022)
3.2.2 Global Neutropenia Biologic Drug Treatment Revenue Market Share by Company (2020-2022)
3.3 Global Neutropenia Biologic Drug Treatment Sale Price by Company
3.4 Key Manufacturers Neutropenia Biologic Drug Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neutropenia Biologic Drug Treatment Product Location Distribution
3.4.2 Players Neutropenia Biologic Drug Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NEUTROPENIA BIOLOGIC DRUG TREATMENT BY GEOGRAPHIC REGION
4.1 World Historic Neutropenia Biologic Drug Treatment Market Size by Geographic Region (2017-2022)
4.1.1 Global Neutropenia Biologic Drug Treatment Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Neutropenia Biologic Drug Treatment Annual Revenue by Geographic Region
4.2 World Historic Neutropenia Biologic Drug Treatment Market Size by Country/Region (2017-2022)
4.2.1 Global Neutropenia Biologic Drug Treatment Annual Sales by Country/Region (2017-2022)
4.2.2 Global Neutropenia Biologic Drug Treatment Annual Revenue by Country/Region
4.3 Americas Neutropenia Biologic Drug Treatment Sales Growth
4.4 APAC Neutropenia Biologic Drug Treatment Sales Growth
4.5 Europe Neutropenia Biologic Drug Treatment Sales Growth
4.6 Middle East & Africa Neutropenia Biologic Drug Treatment Sales Growth
5 AMERICAS
5.1 Americas Neutropenia Biologic Drug Treatment Sales by Country
5.1.1 Americas Neutropenia Biologic Drug Treatment Sales by Country (2017-2022)
5.1.2 Americas Neutropenia Biologic Drug Treatment Revenue by Country (2017-2022)
5.2 Americas Neutropenia Biologic Drug Treatment Sales by Type
5.3 Americas Neutropenia Biologic Drug Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neutropenia Biologic Drug Treatment Sales by Region
6.1.1 APAC Neutropenia Biologic Drug Treatment Sales by Region (2017-2022)
6.1.2 APAC Neutropenia Biologic Drug Treatment Revenue by Region (2017-2022)
6.2 APAC Neutropenia Biologic Drug Treatment Sales by Type
6.3 APAC Neutropenia Biologic Drug Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neutropenia Biologic Drug Treatment by Country
7.1.1 Europe Neutropenia Biologic Drug Treatment Sales by Country (2017-2022)
7.1.2 Europe Neutropenia Biologic Drug Treatment Revenue by Country (2017-2022)
7.2 Europe Neutropenia Biologic Drug Treatment Sales by Type
7.3 Europe Neutropenia Biologic Drug Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neutropenia Biologic Drug Treatment by Country
8.1.1 Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Country (2017-2022)
8.1.2 Middle East & Africa Neutropenia Biologic Drug Treatment Revenue by Country (2017-2022)
8.2 Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Type
8.3 Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neutropenia Biologic Drug Treatment
10.3 Manufacturing Process Analysis of Neutropenia Biologic Drug Treatment
10.4 Industry Chain Structure of Neutropenia Biologic Drug Treatment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neutropenia Biologic Drug Treatment Distributors
11.3 Neutropenia Biologic Drug Treatment Customer
12 WORLD FORECAST REVIEW FOR NEUTROPENIA BIOLOGIC DRUG TREATMENT BY GEOGRAPHIC REGION
12.1 Global Neutropenia Biologic Drug Treatment Market Size Forecast by Region
12.1.1 Global Neutropenia Biologic Drug Treatment Forecast by Region (2023-2028)
12.1.2 Global Neutropenia Biologic Drug Treatment Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neutropenia Biologic Drug Treatment Forecast by Type
12.7 Global Neutropenia Biologic Drug Treatment Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Neutropenia Biologic Drug Treatment Product Offered
13.1.3 Amgen Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Neutropenia Biologic Drug Treatment Product Offered
13.2.3 Novartis Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Neutropenia Biologic Drug Treatment Product Offered
13.3.3 Pfizer Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Baxter International
13.4.1 Baxter International Company Information
13.4.2 Baxter International Neutropenia Biologic Drug Treatment Product Offered
13.4.3 Baxter International Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Baxter International Main Business Overview
13.4.5 Baxter International Latest Developments
13.5 Cellerant Therapeutics
13.5.1 Cellerant Therapeutics Company Information
13.5.2 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Offered
13.5.3 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Cellerant Therapeutics Main Business Overview
13.5.5 Cellerant Therapeutics Latest Developments
13.6 Dong-A ST Co.,Ltd.
13.6.1 Dong-A ST Co.,Ltd. Company Information
13.6.2 Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Product Offered
13.6.3 Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Dong-A ST Co.,Ltd. Main Business Overview
13.6.5 Dong-A ST Co.,Ltd. Latest Developments
13.7 Myelo Therapeutics GmbH
13.7.1 Myelo Therapeutics GmbH Company Information
13.7.2 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Product Offered
13.7.3 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Myelo Therapeutics GmbH Main Business Overview
13.7.5 Myelo Therapeutics GmbH Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi Neutropenia Biologic Drug Treatment Product Offered
13.8.3 Sanofi Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Teva Pharmaceutical Industries Ltd.
13.9.1 Teva Pharmaceutical Industries Ltd. Company Information
13.9.2 Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Product Offered
13.9.3 Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.9.5 Teva Pharmaceutical Industries Ltd. Latest Developments
13.10 Kyowa Kirin
13.10.1 Kyowa Kirin Company Information
13.10.2 Kyowa Kirin Neutropenia Biologic Drug Treatment Product Offered
13.10.3 Kyowa Kirin Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Kyowa Kirin Main Business Overview
13.10.5 Kyowa Kirin Latest Developments
13.11 CVS Health
13.11.1 CVS Health Company Information
13.11.2 CVS Health Neutropenia Biologic Drug Treatment Product Offered
13.11.3 CVS Health Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 CVS Health Main Business Overview
13.11.5 CVS Health Latest Developments
13.12 Partner Therapeutics
13.12.1 Partner Therapeutics Company Information
13.12.2 Partner Therapeutics Neutropenia Biologic Drug Treatment Product Offered
13.12.3 Partner Therapeutics Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Partner Therapeutics Main Business Overview
13.12.5 Partner Therapeutics Latest Developments
13.13 Enzychem Lifesciences Corporation
13.13.1 Enzychem Lifesciences Corporation Company Information
13.13.2 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Offered
13.13.3 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Enzychem Lifesciences Corporation Main Business Overview
13.13.5 Enzychem Lifesciences Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neutropenia Biologic Drug Treatment Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Neutropenia Biologic Drug Treatment Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Filgrastim
Table 4. Major Players of Pegfilgrastim
Table 5. Major Players of Lenograstim
Table 6. Major Players of Lipegfilgrastim
Table 7. Major Players of Sargramostim
Table 8. Global Neutropenia Biologic Drug Treatment Sales by Type (2017-2022) & (K Units)
Table 9. Global Neutropenia Biologic Drug Treatment Sales Market Share by Type (2017-2022)
Table 10. Global Neutropenia Biologic Drug Treatment Revenue by Type (2017-2022) & ($ million)
Table 11. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Type (2017-2022)
Table 12. Global Neutropenia Biologic Drug Treatment Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Neutropenia Biologic Drug Treatment Sales by Application (2017-2022) & (K Units)
Table 14. Global Neutropenia Biologic Drug Treatment Sales Market Share by Application (2017-2022)
Table 15. Global Neutropenia Biologic Drug Treatment Revenue by Application (2017-2022)
Table 16. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Application (2017-2022)
Table 17. Global Neutropenia Biologic Drug Treatment Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Neutropenia Biologic Drug Treatment Sales by Company (2020-2022) & (K Units)
Table 19. Global Neutropenia Biologic Drug Treatment Sales Market Share by Company (2020-2022)
Table 20. Global Neutropenia Biologic Drug Treatment Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Company (2020-2022)
Table 22. Global Neutropenia Biologic Drug Treatment Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Neutropenia Biologic Drug Treatment Producing Area Distribution and Sales Area
Table 24. Players Neutropenia Biologic Drug Treatment Products Offered
Table 25. Neutropenia Biologic Drug Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Neutropenia Biologic Drug Treatment Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Neutropenia Biologic Drug Treatment Sales Market Share Geographic Region (2017-2022)
Table 30. Global Neutropenia Biologic Drug Treatment Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Neutropenia Biologic Drug Treatment Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Neutropenia Biologic Drug Treatment Sales Market Share by Country/Region (2017-2022)
Table 34. Global Neutropenia Biologic Drug Treatment Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Neutropenia Biologic Drug Treatment Sales by Country (2017-2022) & (K Units)
Table 37. Americas Neutropenia Biologic Drug Treatment Sales Market Share by Country (2017-2022)
Table 38. Americas Neutropenia Biologic Drug Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Neutropenia Biologic Drug Treatment Revenue Market Share by Country (2017-2022)
Table 40. Americas Neutropenia Biologic Drug Treatment Sales by Type (2017-2022) & (K Units)
Table 41. Americas Neutropenia Biologic Drug Treatment Sales Market Share by Type (2017-2022)
Table 42. Americas Neutropenia Biologic Drug Treatment Sales by Application (2017-2022) & (K Units)
Table 43. Americas Neutropenia Biologic Drug Treatment Sales Market Share by Application (2017-2022)
Table 44. APAC Neutropenia Biologic Drug Treatment Sales by Region (2017-2022) & (K Units)
Table 45. APAC Neutropenia Biologic Drug Treatment Sales Market Share by Region (2017-2022)
Table 46. APAC Neutropenia Biologic Drug Treatment Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Neutropenia Biologic Drug Treatment Revenue Market Share by Region (2017-2022)
Table 48. APAC Neutropenia Biologic Drug Treatment Sales by Type (2017-2022) & (K Units)
Table 49. APAC Neutropenia Biologic Drug Treatment Sales Market Share by Type (2017-2022)
Table 50. APAC Neutropenia Biologic Drug Treatment Sales by Application (2017-2022) & (K Units)
Table 51. APAC Neutropenia Biologic Drug Treatment Sales Market Share by Application (2017-2022)
Table 52. Europe Neutropenia Biologic Drug Treatment Sales by Country (2017-2022) & (K Units)
Table 53. Europe Neutropenia Biologic Drug Treatment Sales Market Share by Country (2017-2022)
Table 54. Europe Neutropenia Biologic Drug Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Neutropenia Biologic Drug Treatment Revenue Market Share by Country (2017-2022)
Table 56. Europe Neutropenia Biologic Drug Treatment Sales by Type (2017-2022) & (K Units)
Table 57. Europe Neutropenia Biologic Drug Treatment Sales Market Share by Type (2017-2022)
Table 58. Europe Neutropenia Biologic Drug Treatment Sales by Application (2017-2022) & (K Units)
Table 59. Europe Neutropenia Biologic Drug Treatment Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Neutropenia Biologic Drug Treatment
Table 69. Key Market Challenges & Risks of Neutropenia Biologic Drug Treatment
Table 70. Key Industry Trends of Neutropenia Biologic Drug Treatment
Table 71. Neutropenia Biologic Drug Treatment Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Neutropenia Biologic Drug Treatment Distributors List
Table 74. Neutropenia Biologic Drug Treatment Customer List
Table 75. Global Neutropenia Biologic Drug Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Neutropenia Biologic Drug Treatment Sales Market Forecast by Region
Table 77. Global Neutropenia Biologic Drug Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Neutropenia Biologic Drug Treatment Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Neutropenia Biologic Drug Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Neutropenia Biologic Drug Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Neutropenia Biologic Drug Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Neutropenia Biologic Drug Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Neutropenia Biologic Drug Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Neutropenia Biologic Drug Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Neutropenia Biologic Drug Treatment Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Neutropenia Biologic Drug Treatment Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Neutropenia Biologic Drug Treatment Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Neutropenia Biologic Drug Treatment Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Neutropenia Biologic Drug Treatment Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Neutropenia Biologic Drug Treatment Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Neutropenia Biologic Drug Treatment Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Neutropenia Biologic Drug Treatment Revenue Market Share Forecast by Application (2023-2028)
Table 95. Amgen Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 96. Amgen Neutropenia Biologic Drug Treatment Product Offered
Table 97. Amgen Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. Amgen Main Business
Table 99. Amgen Latest Developments
Table 100. Novartis Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 101. Novartis Neutropenia Biologic Drug Treatment Product Offered
Table 102. Novartis Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Novartis Main Business
Table 104. Novartis Latest Developments
Table 105. Pfizer Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 106. Pfizer Neutropenia Biologic Drug Treatment Product Offered
Table 107. Pfizer Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Pfizer Main Business
Table 109. Pfizer Latest Developments
Table 110. Baxter International Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 111. Baxter International Neutropenia Biologic Drug Treatment Product Offered
Table 112. Baxter International Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Baxter International Main Business
Table 114. Baxter International Latest Developments
Table 115. Cellerant Therapeutics Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 116. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Offered
Table 117. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. Cellerant Therapeutics Main Business
Table 119. Cellerant Therapeutics Latest Developments
Table 120. Dong-A ST Co.,Ltd. Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 121. Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Product Offered
Table 122. Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Dong-A ST Co.,Ltd. Main Business
Table 124. Dong-A ST Co.,Ltd. Latest Developments
Table 125. Myelo Therapeutics GmbH Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 126. Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Product Offered
Table 127. Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. Myelo Therapeutics GmbH Main Business
Table 129. Myelo Therapeutics GmbH Latest Developments
Table 130. Sanofi Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 131. Sanofi Neutropenia Biologic Drug Treatment Product Offered
Table 132. Sanofi Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. Sanofi Main Business
Table 134. Sanofi Latest Developments
Table 135. Teva Pharmaceutical Industries Ltd. Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 136. Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Product Offered
Table 137. Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 138. Teva Pharmaceutical Industries Ltd. Main Business
Table 139. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 140. Kyowa Kirin Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 141. Kyowa Kirin Neutropenia Biologic Drug Treatment Product Offered
Table 142. Kyowa Kirin Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 143. Kyowa Kirin Main Business
Table 144. Kyowa Kirin Latest Developments
Table 145. CVS Health Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 146. CVS Health Neutropenia Biologic Drug Treatment Product Offered
Table 147. CVS Health Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 148. CVS Health Main Business
Table 149. CVS Health Latest Developments
Table 150. Partner Therapeutics Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 151. Partner Therapeutics Neutropenia Biologic Drug Treatment Product Offered
Table 152. Partner Therapeutics Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 153. Partner Therapeutics Main Business
Table 154. Partner Therapeutics Latest Developments
Table 155. Enzychem Lifesciences Corporation Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 156. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Offered
Table 157. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 158. Enzychem Lifesciences Corporation Main Business
Table 159. Enzychem Lifesciences Corporation Latest Developments
Table 1. Neutropenia Biologic Drug Treatment Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Neutropenia Biologic Drug Treatment Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Filgrastim
Table 4. Major Players of Pegfilgrastim
Table 5. Major Players of Lenograstim
Table 6. Major Players of Lipegfilgrastim
Table 7. Major Players of Sargramostim
Table 8. Global Neutropenia Biologic Drug Treatment Sales by Type (2017-2022) & (K Units)
Table 9. Global Neutropenia Biologic Drug Treatment Sales Market Share by Type (2017-2022)
Table 10. Global Neutropenia Biologic Drug Treatment Revenue by Type (2017-2022) & ($ million)
Table 11. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Type (2017-2022)
Table 12. Global Neutropenia Biologic Drug Treatment Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Neutropenia Biologic Drug Treatment Sales by Application (2017-2022) & (K Units)
Table 14. Global Neutropenia Biologic Drug Treatment Sales Market Share by Application (2017-2022)
Table 15. Global Neutropenia Biologic Drug Treatment Revenue by Application (2017-2022)
Table 16. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Application (2017-2022)
Table 17. Global Neutropenia Biologic Drug Treatment Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Neutropenia Biologic Drug Treatment Sales by Company (2020-2022) & (K Units)
Table 19. Global Neutropenia Biologic Drug Treatment Sales Market Share by Company (2020-2022)
Table 20. Global Neutropenia Biologic Drug Treatment Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Company (2020-2022)
Table 22. Global Neutropenia Biologic Drug Treatment Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Neutropenia Biologic Drug Treatment Producing Area Distribution and Sales Area
Table 24. Players Neutropenia Biologic Drug Treatment Products Offered
Table 25. Neutropenia Biologic Drug Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Neutropenia Biologic Drug Treatment Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Neutropenia Biologic Drug Treatment Sales Market Share Geographic Region (2017-2022)
Table 30. Global Neutropenia Biologic Drug Treatment Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Neutropenia Biologic Drug Treatment Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Neutropenia Biologic Drug Treatment Sales Market Share by Country/Region (2017-2022)
Table 34. Global Neutropenia Biologic Drug Treatment Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Neutropenia Biologic Drug Treatment Sales by Country (2017-2022) & (K Units)
Table 37. Americas Neutropenia Biologic Drug Treatment Sales Market Share by Country (2017-2022)
Table 38. Americas Neutropenia Biologic Drug Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Neutropenia Biologic Drug Treatment Revenue Market Share by Country (2017-2022)
Table 40. Americas Neutropenia Biologic Drug Treatment Sales by Type (2017-2022) & (K Units)
Table 41. Americas Neutropenia Biologic Drug Treatment Sales Market Share by Type (2017-2022)
Table 42. Americas Neutropenia Biologic Drug Treatment Sales by Application (2017-2022) & (K Units)
Table 43. Americas Neutropenia Biologic Drug Treatment Sales Market Share by Application (2017-2022)
Table 44. APAC Neutropenia Biologic Drug Treatment Sales by Region (2017-2022) & (K Units)
Table 45. APAC Neutropenia Biologic Drug Treatment Sales Market Share by Region (2017-2022)
Table 46. APAC Neutropenia Biologic Drug Treatment Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Neutropenia Biologic Drug Treatment Revenue Market Share by Region (2017-2022)
Table 48. APAC Neutropenia Biologic Drug Treatment Sales by Type (2017-2022) & (K Units)
Table 49. APAC Neutropenia Biologic Drug Treatment Sales Market Share by Type (2017-2022)
Table 50. APAC Neutropenia Biologic Drug Treatment Sales by Application (2017-2022) & (K Units)
Table 51. APAC Neutropenia Biologic Drug Treatment Sales Market Share by Application (2017-2022)
Table 52. Europe Neutropenia Biologic Drug Treatment Sales by Country (2017-2022) & (K Units)
Table 53. Europe Neutropenia Biologic Drug Treatment Sales Market Share by Country (2017-2022)
Table 54. Europe Neutropenia Biologic Drug Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Neutropenia Biologic Drug Treatment Revenue Market Share by Country (2017-2022)
Table 56. Europe Neutropenia Biologic Drug Treatment Sales by Type (2017-2022) & (K Units)
Table 57. Europe Neutropenia Biologic Drug Treatment Sales Market Share by Type (2017-2022)
Table 58. Europe Neutropenia Biologic Drug Treatment Sales by Application (2017-2022) & (K Units)
Table 59. Europe Neutropenia Biologic Drug Treatment Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Neutropenia Biologic Drug Treatment
Table 69. Key Market Challenges & Risks of Neutropenia Biologic Drug Treatment
Table 70. Key Industry Trends of Neutropenia Biologic Drug Treatment
Table 71. Neutropenia Biologic Drug Treatment Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Neutropenia Biologic Drug Treatment Distributors List
Table 74. Neutropenia Biologic Drug Treatment Customer List
Table 75. Global Neutropenia Biologic Drug Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Neutropenia Biologic Drug Treatment Sales Market Forecast by Region
Table 77. Global Neutropenia Biologic Drug Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Neutropenia Biologic Drug Treatment Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Neutropenia Biologic Drug Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Neutropenia Biologic Drug Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Neutropenia Biologic Drug Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Neutropenia Biologic Drug Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Neutropenia Biologic Drug Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Neutropenia Biologic Drug Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Neutropenia Biologic Drug Treatment Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Neutropenia Biologic Drug Treatment Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Neutropenia Biologic Drug Treatment Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Neutropenia Biologic Drug Treatment Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Neutropenia Biologic Drug Treatment Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Neutropenia Biologic Drug Treatment Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Neutropenia Biologic Drug Treatment Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Neutropenia Biologic Drug Treatment Revenue Market Share Forecast by Application (2023-2028)
Table 95. Amgen Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 96. Amgen Neutropenia Biologic Drug Treatment Product Offered
Table 97. Amgen Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. Amgen Main Business
Table 99. Amgen Latest Developments
Table 100. Novartis Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 101. Novartis Neutropenia Biologic Drug Treatment Product Offered
Table 102. Novartis Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Novartis Main Business
Table 104. Novartis Latest Developments
Table 105. Pfizer Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 106. Pfizer Neutropenia Biologic Drug Treatment Product Offered
Table 107. Pfizer Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Pfizer Main Business
Table 109. Pfizer Latest Developments
Table 110. Baxter International Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 111. Baxter International Neutropenia Biologic Drug Treatment Product Offered
Table 112. Baxter International Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Baxter International Main Business
Table 114. Baxter International Latest Developments
Table 115. Cellerant Therapeutics Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 116. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Offered
Table 117. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. Cellerant Therapeutics Main Business
Table 119. Cellerant Therapeutics Latest Developments
Table 120. Dong-A ST Co.,Ltd. Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 121. Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Product Offered
Table 122. Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Dong-A ST Co.,Ltd. Main Business
Table 124. Dong-A ST Co.,Ltd. Latest Developments
Table 125. Myelo Therapeutics GmbH Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 126. Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Product Offered
Table 127. Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. Myelo Therapeutics GmbH Main Business
Table 129. Myelo Therapeutics GmbH Latest Developments
Table 130. Sanofi Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 131. Sanofi Neutropenia Biologic Drug Treatment Product Offered
Table 132. Sanofi Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. Sanofi Main Business
Table 134. Sanofi Latest Developments
Table 135. Teva Pharmaceutical Industries Ltd. Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 136. Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Product Offered
Table 137. Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 138. Teva Pharmaceutical Industries Ltd. Main Business
Table 139. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 140. Kyowa Kirin Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 141. Kyowa Kirin Neutropenia Biologic Drug Treatment Product Offered
Table 142. Kyowa Kirin Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 143. Kyowa Kirin Main Business
Table 144. Kyowa Kirin Latest Developments
Table 145. CVS Health Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 146. CVS Health Neutropenia Biologic Drug Treatment Product Offered
Table 147. CVS Health Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 148. CVS Health Main Business
Table 149. CVS Health Latest Developments
Table 150. Partner Therapeutics Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 151. Partner Therapeutics Neutropenia Biologic Drug Treatment Product Offered
Table 152. Partner Therapeutics Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 153. Partner Therapeutics Main Business
Table 154. Partner Therapeutics Latest Developments
Table 155. Enzychem Lifesciences Corporation Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors
Table 156. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Offered
Table 157. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 158. Enzychem Lifesciences Corporation Main Business
Table 159. Enzychem Lifesciences Corporation Latest Developments
LIST OF FIGURES
Figure 1. Picture of Neutropenia Biologic Drug Treatment
Figure 2. Neutropenia Biologic Drug Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neutropenia Biologic Drug Treatment Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Neutropenia Biologic Drug Treatment Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Neutropenia Biologic Drug Treatment Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Filgrastim
Figure 10. Product Picture of Pegfilgrastim
Figure 11. Product Picture of Lenograstim
Figure 12. Product Picture of Lipegfilgrastim
Figure 13. Product Picture of Sargramostim
Figure 14. Global Neutropenia Biologic Drug Treatment Sales Market Share by Type in 2021
Figure 15. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Type (2017-2022)
Figure 16. Neutropenia Biologic Drug Treatment Consumed in Retail Pharmacies
Figure 17. Global Neutropenia Biologic Drug Treatment Market: Retail Pharmacies (2017-2022) & (K Units)
Figure 18. Neutropenia Biologic Drug Treatment Consumed in Hospital Pharmacies
Figure 19. Global Neutropenia Biologic Drug Treatment Market: Hospital Pharmacies (2017-2022) & (K Units)
Figure 20. Neutropenia Biologic Drug Treatment Consumed in Online Pharmacies
Figure 21. Global Neutropenia Biologic Drug Treatment Market: Online Pharmacies (2017-2022) & (K Units)
Figure 22. Global Neutropenia Biologic Drug Treatment Sales Market Share by Application (2017-2022)
Figure 23. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Application in 2021
Figure 24. Neutropenia Biologic Drug Treatment Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Company in 2021
Figure 26. Global Neutropenia Biologic Drug Treatment Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Geographic Region in 2021
Figure 28. Global Neutropenia Biologic Drug Treatment Sales Market Share by Region (2017-2022)
Figure 29. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Country/Region in 2021
Figure 30. Americas Neutropenia Biologic Drug Treatment Sales 2017-2022 (K Units)
Figure 31. Americas Neutropenia Biologic Drug Treatment Revenue 2017-2022 ($ Millions)
Figure 32. APAC Neutropenia Biologic Drug Treatment Sales 2017-2022 (K Units)
Figure 33. APAC Neutropenia Biologic Drug Treatment Revenue 2017-2022 ($ Millions)
Figure 34. Europe Neutropenia Biologic Drug Treatment Sales 2017-2022 (K Units)
Figure 35. Europe Neutropenia Biologic Drug Treatment Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Neutropenia Biologic Drug Treatment Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue 2017-2022 ($ Millions)
Figure 38. Americas Neutropenia Biologic Drug Treatment Sales Market Share by Country in 2021
Figure 39. Americas Neutropenia Biologic Drug Treatment Revenue Market Share by Country in 2021
Figure 40. United States Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Neutropenia Biologic Drug Treatment Sales Market Share by Region in 2021
Figure 45. APAC Neutropenia Biologic Drug Treatment Revenue Market Share by Regions in 2021
Figure 46. China Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Neutropenia Biologic Drug Treatment Sales Market Share by Country in 2021
Figure 53. Europe Neutropenia Biologic Drug Treatment Revenue Market Share by Country in 2021
Figure 54. Germany Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue Market Share by Country in 2021
Figure 61. Egypt Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Neutropenia Biologic Drug Treatment in 2021
Figure 67. Manufacturing Process Analysis of Neutropenia Biologic Drug Treatment
Figure 68. Industry Chain Structure of Neutropenia Biologic Drug Treatment
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Figure 1. Picture of Neutropenia Biologic Drug Treatment
Figure 2. Neutropenia Biologic Drug Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neutropenia Biologic Drug Treatment Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Neutropenia Biologic Drug Treatment Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Neutropenia Biologic Drug Treatment Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Filgrastim
Figure 10. Product Picture of Pegfilgrastim
Figure 11. Product Picture of Lenograstim
Figure 12. Product Picture of Lipegfilgrastim
Figure 13. Product Picture of Sargramostim
Figure 14. Global Neutropenia Biologic Drug Treatment Sales Market Share by Type in 2021
Figure 15. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Type (2017-2022)
Figure 16. Neutropenia Biologic Drug Treatment Consumed in Retail Pharmacies
Figure 17. Global Neutropenia Biologic Drug Treatment Market: Retail Pharmacies (2017-2022) & (K Units)
Figure 18. Neutropenia Biologic Drug Treatment Consumed in Hospital Pharmacies
Figure 19. Global Neutropenia Biologic Drug Treatment Market: Hospital Pharmacies (2017-2022) & (K Units)
Figure 20. Neutropenia Biologic Drug Treatment Consumed in Online Pharmacies
Figure 21. Global Neutropenia Biologic Drug Treatment Market: Online Pharmacies (2017-2022) & (K Units)
Figure 22. Global Neutropenia Biologic Drug Treatment Sales Market Share by Application (2017-2022)
Figure 23. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Application in 2021
Figure 24. Neutropenia Biologic Drug Treatment Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Company in 2021
Figure 26. Global Neutropenia Biologic Drug Treatment Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Geographic Region in 2021
Figure 28. Global Neutropenia Biologic Drug Treatment Sales Market Share by Region (2017-2022)
Figure 29. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Country/Region in 2021
Figure 30. Americas Neutropenia Biologic Drug Treatment Sales 2017-2022 (K Units)
Figure 31. Americas Neutropenia Biologic Drug Treatment Revenue 2017-2022 ($ Millions)
Figure 32. APAC Neutropenia Biologic Drug Treatment Sales 2017-2022 (K Units)
Figure 33. APAC Neutropenia Biologic Drug Treatment Revenue 2017-2022 ($ Millions)
Figure 34. Europe Neutropenia Biologic Drug Treatment Sales 2017-2022 (K Units)
Figure 35. Europe Neutropenia Biologic Drug Treatment Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Neutropenia Biologic Drug Treatment Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue 2017-2022 ($ Millions)
Figure 38. Americas Neutropenia Biologic Drug Treatment Sales Market Share by Country in 2021
Figure 39. Americas Neutropenia Biologic Drug Treatment Revenue Market Share by Country in 2021
Figure 40. United States Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Neutropenia Biologic Drug Treatment Sales Market Share by Region in 2021
Figure 45. APAC Neutropenia Biologic Drug Treatment Revenue Market Share by Regions in 2021
Figure 46. China Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Neutropenia Biologic Drug Treatment Sales Market Share by Country in 2021
Figure 53. Europe Neutropenia Biologic Drug Treatment Revenue Market Share by Country in 2021
Figure 54. Germany Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue Market Share by Country in 2021
Figure 61. Egypt Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Neutropenia Biologic Drug Treatment in 2021
Figure 67. Manufacturing Process Analysis of Neutropenia Biologic Drug Treatment
Figure 68. Industry Chain Structure of Neutropenia Biologic Drug Treatment
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
